UTHR 240719 300.00P (UTHR240719P300000) Stock Options, News & Quotes

US OptionsDetailed Quotes

UTHR240719P300000

Watchlist

2.40
0.000.00%

15min DelayClose Jul 16 10:07 ET

0.00High0.00Low

Intraday

5D
Daily

News

HC Wainwright Adjusts Price Target on United Therapeutics to $400 From $300, Maintains Buy Rating
MT NewswiresJul 25 10:45 ET · Ratings
United Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesJul 25 06:37 ET
H.C. Wainwright Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $400
Moomoo NewsJul 25 06:33 ET · Ratings
United Therapeutics Analyst Ratings
BenzingaJul 25 06:26 ET · Ratings
Express News | United Therapeutics Corporation : H.c. Wainwright Raises Target Price to $400 From $300
ReutersJul 25 06:07 ET
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
BusinesswireJul 24 07:00 ET

Comments

Moomoo News AU

Jul 10 04:25

Columns Australia's H2 2024 investment landscape: how to seize market opportunities?

Jinta Hong, CFA
Background
As we enter the second half of 2024, the global financial landscape remains dynamic, influenced by international relations and economic policies. While major markets like the US, Japan, India, and parts of Europe have seen significant growth, Australia has faced challenges such as inflation and weak Chinese economic performance. The $S&P/ASX 200(.XJO.AU)$ index reached a historic peak in April ...

2024 half-year recap: Tell us your trading story

Tonyco

Jul 3 23:49

$United Therapeutics(UTHR.US)$
lol that is a shit ton of inside selling all at the end of June

Meltyy

May 12 21:23

🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics(UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Liquidia(LQDA.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$MorphoSys(MOR.US)$ Phase 3
$Immunocore(IMCR.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$AstraZeneca(AZN.US)$ Phase 3
$Capricor Therapeutics(CAPR.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3...

Meltyy

Apr 18 03:34

🎯 Ph 3 readouts in Q2 2024...

$Travere Therapeutic(TVTX.US)$ Phase 3
$CG Oncology(CGON.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3
$Insmed(INSM.US)$ Phase 3
$GlycoMimetics(GLYC.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$Lyra Therapeutics(LYRA.US)$ Phase 3
$Citius Pharmaceuticals(CTXR.US)$ Phase 3
$Jaguar Health(JAGX.US)$ Phas...

zcole1101

Jan 5 01:02

Are you a high net profit margin lover? So you will like these 1⃣2⃣ stocks with a net profit margin above 4⃣0⃣%
🇺🇸 Texas Pacific Land $Texas Pacific Land(TPL.US)$ 63.3%
🇸🇪 Evolution $Evotec(EVO.US)$ 59.3%
🇺🇸 CME Group $CME Group(CME.US)$ 57.1%
🇺🇸 Visa $Visa(V.US)$ 55.3%
🇬🇧 Rightmove $RIGHTMOVE ADR(RTMVY.US)$ 54.8%
🇺🇸 Verisign $VeriSign(VRSN.US)$ $50.1%
🇦🇺 Pro Medicus $Pingtan Marine Enterprise(PME.US)$ 49.8%
🇺🇸 NVidia $NVIDIA(NVDA.US)$ 47.3%
🇺🇸 Mastercard $MasterCard(MA.US)$ 45.1%
🇫🇷 GTT $GTT Communications, Inc.(GTTN.US)$ 44.8%...